These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7475514)

  • 1. Failure of aspirin and diltiazem to prevent the formation of acute coronary thrombi in dogs.
    Morishima Y; Tanaka T; Watanabe K; Shibutani T; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 May; 17(4):273-7. PubMed ID: 7475514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
    Lewis GD; Witzke C; Colon-Hernandez P; Guerrero JL; Bloch KD; Semigran MJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1471-7. PubMed ID: 16580539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention by DV-7028, a selective 5-HT2 receptor antagonist, of the formation of coronary thrombi in dogs.
    Morishima Y; Tanaka T; Watanabe K; Igarashi T; Yasuoka M; Shibano T
    Cardiovasc Res; 1991 Sep; 25(9):727-30. PubMed ID: 1799906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin does not potentiate effect of suboptimal dose of the thrombin inhibitor inogatran during coronary thrombolysis.
    Chen LY; Nichols WW; Mattsson C; Teger-Nilson AC; Wallin R; Saldeen TG; Mehta JL
    Cardiovasc Res; 1995 Dec; 30(6):866-74. PubMed ID: 8746200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
    Beaughard M; Brasset M; John G; Massingham R
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo inhibition of platelet aggregation and occlusive coronary thrombus formation by a new calcium antagonist (R023-6152).
    Sordahl LA; Rex KA; Benedict CR
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):504-10. PubMed ID: 1724526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. II. Adjunctive therapy with r-hirudin.
    Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):203-11. PubMed ID: 7511748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diltiazem on experimental coronary artery thrombosis in dogs.
    Schumacher WA; Lucchesi BR
    Pharmacology; 1990; 41(1):16-23. PubMed ID: 2236203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beneficial effects of diltiazem on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):679-83. PubMed ID: 15932731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
    Mickelson JK; Hoff PT; Homeister JW; Fantone JC; Lucchesi BR
    J Am Coll Cardiol; 1993 Feb; 21(2):502-10. PubMed ID: 8426017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
    White BP; Sullivan AT; Lumley P
    Thromb Haemost; 1994 Mar; 71(3):366-74. PubMed ID: 8029802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
    Jun L; Arnout J; Vanhove P; Dol F; Lormeau JC; Herbert JM; Collen D; Van de Werf F
    Coron Artery Dis; 1995 Mar; 6(3):257-63. PubMed ID: 7788040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of anti-platelet agents as adjuncts to tissue plasminogen activator in a dog model of occlusive coronary thrombosis.
    McAuliffe SJ; Moors JA; Jones HB
    Br J Pharmacol; 1994 May; 112(1):272-6. PubMed ID: 8032650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ticlopidine in the prevention of thrombus formation after percutaneous transluminal coronary angioplasty (PTCA).
    Chotinaiwattarakul C; Mahanonda N; Kangkagate C; Chaithiraphan S
    J Med Assoc Thai; 1997 Feb; 80(2):76-80. PubMed ID: 9078690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of left ventricular thrombi in patients with acute anterior myocardial infarction treated with thrombolytics.
    Mooe T; Teien DE; Karp KH; Eriksson P
    Coron Artery Dis; 1995 Sep; 6(9):703-7. PubMed ID: 8747875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thrombosis by a novel platelet selective S-nitrosothiol compound without hemodynamic side effects.
    Vilahur G; Baldellou MI; Segalés E; Salas E; Badimon L
    Cardiovasc Res; 2004 Mar; 61(4):806-16. PubMed ID: 14985078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.